Trial intelligence / Profile preview

ASA in knee osteoarthritis

NCT04636229Phase 3Completed

Sponsor
Organogenesis
Start
Dec 2020
Primary completion
Jul 2023
Modality
Biologic
Countries
1
01

Overview

A Phase 3 trial of amniotic suspension allograft in knee osteoarthritis (OA), sponsored by Organogenesis. Started Dec 2020; status: completed.

02

Drugs

amniotic suspension allograft
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04636229.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04636229.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call